Cart
sales@molnova.com
8-Oxoepiberberine
CAS No. 19716-60-0
8-Oxoepiberberine( Oxyepiberberine )
Catalog No. M23891 CAS No. 19716-60-0
8-Oxoepiberberine is an alkaloid metabolite in the plasma after oral administration of Zuojin formula, a traditional chinese medicine used to treat gastrointestinal disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 155 | In Stock |
|
| 10MG | 250 | In Stock |
|
| 25MG | 424 | In Stock |
|
| 50MG | 600 | In Stock |
|
| 100MG | 824 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name8-Oxoepiberberine
-
NoteResearch use only, not for human use.
-
Brief Description8-Oxoepiberberine is an alkaloid metabolite in the plasma after oral administration of Zuojin formula, a traditional chinese medicine used to treat gastrointestinal disease.
-
Description8-Oxoepiberberine is an alkaloid metabolite in the plasma after oral administration of Zuojin formula, a traditional chinese medicine used to treat gastrointestinal disease.
-
In Vitro——
-
In Vivo——
-
SynonymsOxyepiberberine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number19716-60-0
-
Formula Weight351.4
-
Molecular FormulaC20H17NO5
-
Purity>98% (HPLC)
-
SolubilityDMSO:5 mM
-
SMILESO=C1N2CCC3=CC(OC)=C(OC)C=C3C2=CC4=CC=C(OCO5)C5=C14
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Qian P , Zhang Y B , Yang Y F , et al. Pharmacokinetics Studies of 12 Alkaloids in Rat Plasma after Oral Administration of Zuojin and Fan-Zuojin Formulas[J]. Molecules, 2017, 22(2):214.
molnova catalog
related products
-
Ginsenoside F2
Ginsenoside F2 has antiproliferative activity against breast cancer stem cells (CSCs).
-
Lophanthoidin B
Lophanthoidin B is a natural product isolated from the herbs of Rabdosia lophanthoides.
-
EGFRvIII peptide PEP...
PEPvIII, a peptide sequence from EGFRvIII, was designed to represent a target of glioma and is presented by MHC I/II complexes.
